Definium Therapeutics, Inc. (DFTX) Operating income 2020–2025
Definium Therapeutics, Inc. (DFTX) annual operating income history from SEC filings — each fiscal year as reported.
-$166.3MFY2025 · since FY2020: -$33.0M → -$166.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.3M | -60.0% |
| FY2024 | -$103.9M | -10.7% |
| FY2023 | -$93.9M | -41.5% |
| FY2022 | -$66.3M | +29.3% |
| FY2021 | -$93.9M | -184.1% |
| FY2020 | -$33.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice